AnalystsBruce D. JacksonBruce D. Jackson's Stock Forecasts
AnalystsBruce D. Jackson
Analyst Ranking
Top 10%
#514 out of 5326 analysts
Average Return
+153.56%
Win Rate
65%11 out of 17
Risk vs Reward
Poor
Good
Bruce D. Jackson's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Exact Sciences CorpEXAS | +2,580.11% | $69.59 | $1,865.09 | 2025-11-04 - 2026-03-24 | Strong Buy |
Milestone Scientific IncMLSS | +42.81% | $0.31 | $0.44 | 2025-11-20 - 2026-07-17 | Buy |
Belite Bio IncBLTE | +41.71% | $105.91 | $150.08 | 2025-10-31 - 2026-07-17 | Strong Buy |
Harvard Bioscience IncHBIO | +38.78% | $4.49 | $6.23 | 2025-09-10 - 2026-07-17 | Buy |
Unicycive Therapeutics IncUNCY | +36.55% | $3.94 | $5.38 | 2025-09-15 - 2026-07-17 | Buy |
Bruce D. Jackson Analyst Color
Get additional color on Bruce D. Jackson's coverage of popular stocks
Bruce D. Jackson's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Humacyte IncHUMA | 4 | Buy | $2.00 | +200.75% | Maintains | 2 months ago |
Biofrontera IncBFRI | 1 | Buy | $3.00 | +175.23% | Downgrades | 2 months ago |
Abbott LaboratoriesABT | 1 | Strong Buy | $120.00 | +19.19% | Maintains | 3 months ago |
Unicycive Therapeutics IncUNCY | 2 | Buy | $15.00 | +178.81% | Maintains | 3 months ago |
Genelux CorpGNLX | 1 | Buy | $20.00 | +596.86% | Maintains | 4 months ago |
Harvard Bioscience IncHBIO | 3 | Buy | $6.00 | -3.69% | Maintains | 4 months ago |
Milestone Scientific IncMLSS | 1 | Buy | $1.00 | +128.83% | Maintains | 8 months ago |
Exact Sciences CorpEXAS | 1 | Strong Buy | $75.00 | -95.98% | Maintains | 9 months ago |
Belite Bio IncBLTE | 1 | Strong Buy | $132.00 | -12.05% | Maintains | 9 months ago |
Reviva Pharmaceuticals Holdings IncRVPH | 1 | Buy | $140.00 | +42,324.24% | Maintains | 10 months ago |
Clene IncCLNN | 1 | Strong Buy | $31.00 | +423.65% | Maintains | 10 months ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.